Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CONTACT-SPE: Thrombolysis vs Anticoagulation in Submassive Pulmonary Embolism
NCT02132689Phase 4Completed
- Sponsor
- University Hospital Ostrava
- Start
- Mar 2011
- Primary completion
- May 2015
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 4 trial of tissue-plasminogen activator in pulmonary embolism (PE), sponsored by University Hospital Ostrava. Started Mar 2011; status: completed.
02
Drugs
tissue-plasminogen activator
03
Conditions
pulmonary embolism (PE)
Beyond the preview
Go deeper on NCT02132689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02132689.